Evidence map›Paper›PMID 36271300›Full record

ArticleCell and tissue research2023

Platelet lysate can support the development of a 3D-engineered skin for clinical application.

I Banakh, Md M Rahman, C L Arellano, D C Marks, S Mukherjee, C E Gargett, H Cleland, S Akbarzadeh

Open access · hybridAbstract read
In one paragraph

Article in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

I BanakhSkin Bioengineering Laboratory, Victorian Adult Burns Service, Alfred Health, 89 Commercial Road, Melbourne, Vic, 3181, Australia.
Md M RahmanSkin Bioengineering Laboratory, Victorian Adult Burns Service, Alfred Health, 89 Commercial Road, Melbourne, Vic, 3181, Australia.
C L ArellanoSkin Bioengineering Laboratory, Victorian Adult Burns Service, Alfred Health, 89 Commercial Road, Melbourne, Vic, 3181, Australia.
D C MarksAustralian Red Cross Lifeblood, 17 O'Riordan Street, Alexandria, NSW, Australia.
S MukherjeeThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Vic, Australia.
C E GargettThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Vic, Australia.
H ClelandSkin Bioengineering Laboratory, Victorian Adult Burns Service, Alfred Health, 89 Commercial Road, Melbourne, Vic, 3181, Australia.
S AkbarzadehSkin Bioengineering Laboratory, Victorian Adult Burns Service, Alfred Health, 89 Commercial Road, Melbourne, Vic, 3181, Australia. Shiva.Akbarzadeh@monash.edu.ORCID http://orcid.org/0000-0002-2787-3317
Alfred Health · AUHudson Institute of Medical Research · AUMonash Health · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Safety concerns associated with foetal bovine serum (FBS) have restricted its translation into clinics. We hypothesised that platelet lysate (PL) can be utilised as a safe alternative to produce serum-free 3D-engineered skin. PL supported a short-term expansion of fibroblasts, with negligible replication-induced senescence and directed epidermal stratification. PL-expanded fibroblasts were phenotypically separated into three subpopulations of CD90

Indexed as

Cell ExtractsSkinTissue EngineeringBlood PlateletsCell DifferentiationEpidermisFibroblastsTransforming Growth Factor beta1Cell ExtractsTransforming Growth Factor beta1Collagen IVPlatelet lysatePrimary keratinocytes cultureSenescenceTGF-β1

Identifiers

PMID36271300
PMCPMC9839813
OpenAlexW4307038674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.